This inventor holds 1 USPTO granted patent. Top assignee: Sloan-Kettering Institute for Cancer Research. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: The Innovations of Dongjoo Lee
Introduction
Dongjoo Lee is a prominent inventor based in New York, NY, known for his significant contributions to the field of cancer research. He holds a patent that showcases his innovative approach to glycopeptide constructs, which have potential applications in immunotherapy.
Latest Patents
Dongjoo Lee's patent, titled "Glycopeptide constructs and uses thereof," focuses on glycopeptide conjugates and methods for their production and application. The patent details how certain glycopeptide conjugates incorporate tumor-associated carbohydrate antigens and peptide epitopes. Additionally, it describes cyclic peptide scaffolds that present carbohydrate antigens in a clustered manner, enhancing their immunogenicity.
Career Highlights
Dongjoo Lee is affiliated with the Sloan Kettering Institute for Cancer Research, where he conducts groundbreaking research aimed at improving cancer treatment. His work is characterized by a commitment to advancing scientific knowledge and developing innovative therapeutic strategies.
Collaborations
Throughout his career, Dongjoo Lee has collaborated with esteemed colleagues, including Samuel J. Danishefsky and Jianglong Zhu. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the impact of their research.
Conclusion
Dongjoo Lee's contributions to the field of cancer research through his innovative glycopeptide constructs exemplify the importance of scientific innovation in addressing complex
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile